[Wiley] Multi‐target angiogenesis inhibitor combined with PD‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of EGFR‐TKI therapy

Ddgg23 Post time 2025-6-10 19:43:00 | Show all posts |Read mode
This post will be closed automatically in 2025-06-11 19:42
Reward10points

journal:International Journal of Cancer

Authors:Lian Yu; Yaohua Hu; Jianlin Xu; Rong Qiao; Hua Zhong; Baohui Han; Jinjing Xia; Runbo Zhong

Published date:2023-8-

DOI:10.1002/ijc.34536

PDF link:https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.34536

Article link:https://doi.org/10.1002/ijc.34536

Article Source:Wiley


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Victor90 Post time 2025-6-10 19:43:01 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    50

Return to the list